Aldevron LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aldevron LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0475
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aldevron LLC (Aldevron) is a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services. The company develops and manufactures plasmid deoxyribonucleic acid (Plasmid DNA), proteins and antibodies for research, preclinical and clinical applications serving biotechnology industry. Its antibody development services include protein immunization, antibody sequencing and discovery, peptide and genetic immunization. The company also offers support services in RNA production, gene synthesis; aldevron storage, distribution and stability (ASDS) service and others. The company has operations with manufacturing facilities in Fargo, Madison, the US; and Freiburg, Germany. Aldevron is headquartered in Fargo, North Dakota, the US.

Aldevron LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aldevron LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aldevron LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aldevron LLC, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
TA Associates Invests in Aldevron 10
Partnerships 11
Aldevron to Partner with Myeloma Crowd Research Initiative 11
DNA2.0 And Aldevron Enter Into Agreement For Insect Cell Expression System 12
Licensing Agreements 13
Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 13
Aldevron Enters into Licensing Agreement with Stanford University 14
Aldevron LLC – Key Competitors 15
Aldevron LLC – Key Employees 16
Aldevron LLC – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
May 30, 2018: Aldevron hires Don Kania to board of directors 18
May 15, 2018: Aldevron Names Marc Wolff Chief Financial Officer 19
Aug 17, 2017: Five new employees joined in Aldevron 20
May 23, 2017: Aldevron Names Biomanufacturing Veteran Henry Hebel as New Chief Operating Officer 21
Government and Public Interest 22
Apr 16, 2018: Aldevron to host inaugural Breakthrough Symposium 22
Product News 23
Nov 15, 2017: Aldevron Announces Availability of GMP SpCas9 23
Feb 21, 2018: Aldevron Announces Ready-to-Use AAV Helper Plasmid 24
Other Significant Developments 25
Feb 14, 2017: Aldevron expands manufacturing scale and implements single-use fermentation technology 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Aldevron LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aldevron LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aldevron LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Aldevron LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TA Associates Invests in Aldevron 10
Aldevron to Partner with Myeloma Crowd Research Initiative 11
DNA2.0 And Aldevron Enter Into Agreement For Insect Cell Expression System 12
Aldevron Enters into Licensing Agreement with Integrated DNA Technologies 13
Aldevron Enters into Licensing Agreement with Stanford University 14
Aldevron LLC, Key Competitors 15
Aldevron LLC, Key Employees 16
Aldevron LLC, Other Locations 17
Aldevron LLC, Subsidiaries 17

List of Figures
Aldevron LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aldevron LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aldevron LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Aldevron LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chiome Bioscience Inc (4583)-製薬・医療分野:企業M&A・提携分析
    Summary Chiome Bioscience Inc (Chiome Bioscience) is a healthcare service company that offers research and development of therapies. The company research and develops antibody drugs for the treatment of autoimmune and inflammatory diseases. Its ADLib system is a monoclonal antibody generating system …
  • Bonanza Creek Energy Inc (BCEI):企業の財務・戦略的SWOT分析
    Summary Bonanza Creek Energy Inc (Bonanza Creek) is an exploration and production company, engaged in acquisition, extraction and development of oil and related liquids which are rich in natural gas. The company uses horizontal drilling method for exploration and production of oil and natural gas an …
  • TransCanada Corp (TRP):石油・ガス:M&Aディール及び事業提携情報
    Summary TransCanada Corp (TransCanada) is an energy infrastructure company. It develops and operates energy infrastructure, such as natural gas and liquids pipelines, power generation and gas storage facilities. The company also provides gas storage related services and operates in the regulated and …
  • Mashreqbank psc:企業の戦略・SWOT・財務情報
    Mashreqbank psc - Strategy, SWOT and Corporate Finance Report Summary Mashreqbank psc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Green Energy Technology Inc Ltd (3519):電力:M&Aディール及び事業提携情報
    Summary Green Energy Technology Inc Ltd (Green Energy Technology), a subsidiary of Tatung Company is an alternative energy company that manufactures and markets multi-crystalline solar wafers. The company's products include single-crystalline wafer cuttings, thin film photovoltaic modules, multi-cry …
  • NeuroLogica Corp-医療機器分野:企業M&A・提携分析
    Summary NeuroLogica Corp (NeuroLogica), a subsidiary of Samsung Electronics America Inc is a medical device company that develops, manufactures and markets medical imaging equipment. The company offers digital radiography systems for hospitals and imaging centers, portable CT imaging systems, and ul …
  • Umeme Limited (UMEME):電力:M&Aディール及び事業提携情報
    Summary Umeme Limited (Umeme) is an electricity distribution utility. The company operates, maintains, upgrades, and expands the electricity distribution system in the country. It sources power from Uganda Electricity Transmission Company Limited which purchases energy from all independent power pro …
  • Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析
    Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Intertape Polymer Group Inc (ITP):企業の財務・戦略的SWOT分析
    Intertape Polymer Group Inc (ITP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • El Paso Electric Company:発電所・企業SWOT分析
    El Paso Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • First Philippine Holdings Corp (FPH):企業の財務・戦略的SWOT分析
    First Philippine Holdings Corp (FPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Daiwa House Industry Co Ltd (1925)-エネルギー分野:企業M&A・提携分析
    Summary Daiwa House Industry Co., Ltd. (Daiwa House) is a construction service provider. The company provides diversified real estate solutions such as planning, construction, leasing, management and operation of rental, pre-existing, and new buildings; renovation and real estate agency services. It …
  • China Vanke Co., Ltd.:企業の戦略・SWOT・財務情報
    China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Golden Grain Energy, LLC:企業の戦略的SWOT分析
    Golden Grain Energy, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Ophir Energy Plc (OPHR):石油・ガス:M&Aディール及び事業提携情報
    Summary Ophir Energy Plc (Ophir) is an independent upstream oil and gas company, which explores for and develops oil and gas properties. The company has working interests in assets across Africa and Asia. Ophir has assets in Tanzania, Equatorial Guinea, Kenya, Cote d’Ivoire, and Gabon in Africa; and …
  • SMCP S.A.S (SMCP):企業の財務・戦略的SWOT分析
    SMCP S.A.S (SMCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • O’Reilly Automotive, Inc. (ORLY):企業の財務・戦略的SWOT分析
    Summary O'Reilly Automotive Inc (O’Reilly) is a provider of automotive parts. The company offers automotive parts, tools, equipment, supplies and accessories. The company offers various services such as battery diagnostic testing; battery, wiper and bulb replacement; check and engine light code extr …
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • The Siam Cement Public Co Ltd:企業の戦略・SWOT・財務分析
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ITM Power Plc (ITM):企業の財務・戦略的SWOT分析
    ITM Power Plc (ITM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆